A federal grand jury in Nevada has returned an indictment accusing Dr. Stephen Dubin of orchestrating a roughly $95 million Medicare fraud scheme tied to wound care products, federal prosecutors announced. The case, filed in the District of Nevada, alleges that Dubin—an owner of Dubin Medical Consultants, Inc., known as Wound MD—caused Medicare to pay for amniotic wound allografts that were allegedly medically unnecessary and obtained through unlawful kickbacks and bribes. The accusation centers on billing practices prosecutors say were designed to generate large reimbursements from the federal healthcare program, including for elderly and particularly vulnerable patients.
According to the Department of Justice, prosecutors allege that Dubin and others applied expensive amniotic wound allografts to elderly Medicare beneficiaries without medical necessity. The indictment contends that the defendants used kickbacks and bribes to procure the allografts, ultimately driving Medicare charges far beyond what prosecutors say was warranted clinically. In the government’s description of the alleged conduct, Medicare paid more than $54 million based on what prosecutors characterize as false and fraudulent claims submitted to the program.
Prosecutors also describe the targeted population as including hospice patients—individuals who, in many cases, are already receiving end-of-life care and may have heightened vulnerability. The government’s statement frames the scheme as predatory use of complex medical billing and expensive advanced wound-care materials, with the alleged misuse of products occurring in circumstances where medical necessity was, prosecutors say, absent.
In court documents cited by the government, Dubin is described as a medical doctor and the sole owner of Dubin Medical Consultants, Inc. The indictment reportedly alleges that he arranged for costly allografts to be purchased and then applied these products to patients while concealing the true basis for the treatment and the financial incentives tied to the supplies. The government’s allegations extend beyond the claims themselves to the purported supply-chain arrangement, asserting that illegal payments were used to steer orders and enhance Medicare billings.
The DOJ further alleges that Dubin used proceeds from the scheme to finance an extravagant lifestyle. Prosecutors state that Dubin allegedly funded luxury items, including having multi-million-dollar yachts built for him. This allegation, which prosecutors present as part of the broader pattern of alleged fraud, is used to describe what they say was personal enrichment from Medicare payments obtained through wrongful claims rather than legitimate medical care.
The indictment charges Dubin with conspiracy to commit health care fraud and five counts of health care fraud. Federal prosecutors said that, if convicted, Dubin faces a maximum penalty of 10 years in prison for each count. The case therefore carries significant potential exposure under federal healthcare fraud statutes, reflecting the government’s view of the alleged conduct’s scale and seriousness.
Reporting on the case from major outlets echoes the government’s characterization of the wound-care scheme and adds detail about how illegal kickback arrangements allegedly functioned. According to one account, prosecutors allege that Dubin received reimbursements based on medically unnecessary products and that he allegedly took steps to disguise the true cost of the allografts. The reporting describes claims that Medicare billing amounts were influenced by kickback math and possibly supported by invoices prosecutors say were part of a sham documentation process.
One described mechanism involves the alleged transfer of Medicare reimbursement in stages. In that account, the indictment alleges that Dubin would hand over Medicare’s reimbursement to one of the companies involved, which then transferred funds to another shell company account. Prosecutors say that portion of the reimbursement—reported as 40% in the indictment as summarized by the outlet—was kicked back to Dubin. The same reporting also alleges that the operation used “sham invoices” that did not reflect the kickback percentage, purportedly helping to mask the arrangement from investigators and regulators.
Another part of the narrative, highlighted in coverage of the allegations, is the alleged use of medical documentation and billing codes. Prosecutors portray the case as not simply an error in billing but as a deliberate system to generate payment for advanced wound-care products that, according to the indictment, were not medically justified. In the case of hospice patients and other elderly beneficiaries, prosecutors say the alleged treatment decisions were driven by financial incentives rather than patient need.
On the law enforcement side, the federal investigation involves multiple agencies. The DOJ statement identifies the FBI, the Department of Health and Human Services Office of Inspector General (HHS-OIG), and the Defense Criminal Investigative Service (DCIS) as investigators in the case. Their involvement underscores the government’s focus on both fraud detection within Medicare and the broader effort to pursue healthcare fraud schemes that may involve kickbacks, bribery, and improper billing.
While the indictment outlines prosecutors’ allegations, Dubin has not been convicted, and the charges are subject to the judicial process. Still, the government’s announcement, together with reporting based on court documents, points to an alleged pattern spanning multiple years. One account describes alleged conspiracy conduct occurring between about 2021 and 2024, with the scheme tied to the procurement and use of amniotic wound grafts and to claims submitted to Medicare.
As the case moves forward, federal prosecutors are expected to seek accountability for what they allege was a large-scale fraud of a public healthcare program. The government’s central claims—unnecessary wound treatments, kickback-fueled procurement, and false billing—create a factual framework that will be tested in court. For patients and families relying on Medicare-covered care, the allegations—if proven—raise serious concerns about the misuse of advanced medical products and the vulnerability of elderly beneficiaries.
In the meantime, investigators say the case reflects continued enforcement efforts against healthcare providers and intermediaries who allegedly exploit Medicare through predatory schemes. Prosecutors’ emphasis on the alleged hospice component, along with the alleged scale of payments and the alleged proceeds used to fund a yacht lifestyle, positions the Dubin case as a prominent example of the government’s push to dismantle fraudulent billing operations tied to expensive wound-care technology.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
